| MCD | magnetic circular dichroism; mast-cell degranulation; mean cell diameter; mean of consecutive differ... |
|---|---|
| AAMD | American Association on Mental Deficiency; 미국 정신 박약 협회 |
| AAMD-ABS | American Association on Mental Deficiency-Adaptive Behavior Scale; 미국 정신 박약 협회 적응 행동 척도... |
| AIDS | Acquired Immuno(Immune)-Deficiency Syndrome; 후천성 면역 결핍 증후군 |
| IDA | 1) Imino-Diacetic Acid 2) Iron Deficiency Anemia &nb... |
| dTDP-4-ketorhamnose 3,5-epimerase | <enzyme> Thymidine diphosphate sugars (75-82) is not an active mh Registry number: EC 5.1.3.13 Synonym: dtdp-4-dehydrorhamnose 3,5-epimerase (26 Jun 1999) |
|---|---|
| inositol NAD epimerase | <enzyme> Converts myo-inositol to scyllo-inositol and neoinositol; inosose also formed and reverse reaction Registry number: EC 1.1.1.- (26 Jun 1999) |
| isopenicillin N epimerase | <enzyme> From streptomyces clavuligerus; converts isopenicillin n to penicillin n Registry number: EC 5.1.1.- Synonym: cefd protein (26 Jun 1999) |
| thymidine-diphospho-4-keto-6-deoxyglucose epimerase | <enzyme> Isolated from saccharopolyspora erythraea; catalyses the formation of tdp-4-keto-l-rhamnose from thymidine-diphospho-4-keto-6-deoxy-d-glucose Registry number: EC 5.1.3.- Synonym: tdkd-glucose epimerase, tdp-4-keto-6-deoxyglucose 3,5-epimerase, kde gene product (26 Jun 1999) |
| epimerase | <enzyme> An enzyme that catalyses the reversible conversion of an epimer into its counterpart form. (09 Oct 1997) |
| UDP acetylglucosamine-2-epimerase | <enzyme> Catalyses the formation of n-acetylmannosamine and udp from udp n-acetylglucosamine; minor descriptor (75-82); online and index medicus search carbohydrate isomerases (75-82); minor descriptor (75-82); file maintained to carbohydrate isomerases Registry number: EC 5.1.3.14 Synonym: udp acetylglucosamine 2 epimerase, udp n-acetyl-d-glucosamine 2-epimerase (26 Jun 1999) |
| UDPgalactose 4-epimerase | <enzyme> A necessary enzyme in the metabolism of galactose. It reversibly catalyses the conversion of udpglucose to udpgalactose. NAD+ is an essential component for enzymatic activity. Chemical name: UDPglucose 4-epimerase Registry number: EC 5.1.3.2 (12 Dec 1998) |
| udpglucose 4-epimerase | <enzyme> A necessary enzyme in the metabolism of galactose. It reversibly catalyses the conversion of udpglucose to udpgalactose. NAD+ is an essential component for enzymatic activity. Chemical name: UDPglucose 4-epimerase Registry number: EC 5.1.3.2 (12 Dec 1998) |
| UDPglucuronate 4-epimerase | <enzyme> Uridine diphosphate glucuronic aid (77-82) is not an active mh Chemical name: udpgalacturonate 4-epimerase Registry number: EC 5.1.3.6 (26 Jun 1999) |
| uridine diphosphoglucose 4-epimerase | <enzyme> A necessary enzyme in the metabolism of galactose. It reversibly catalyses the conversion of udpglucose to udpgalactose. NAD+ is an essential component for enzymatic activity. Chemical name: UDPglucose 4-epimerase Registry number: EC 5.1.3.2 (12 Dec 1998) |
| 2-arylpropionyl-CoA epimerase | <enzyme> From rat liver cytosol and mitochondria; catalyses a rapid interconversion between the r- and s-epimers of 2-arylpropionic acids which upon the action of a thioesterase on the r-isomer yields the free acid Registry number: EC 5.1.99.- (26 Jun 1999) |
| L-ribulosephosphate 4-epimerase | <enzyme> Consider also EC 5.1.3.1,ribulosephosphate 3-epimerase Registry number: EC 5.1.3.4 Synonym: l-ribulose 5-phosphate 4-epimerase, rpe1 gene product (26 Jun 1999) |
| abdominal muscle deficiency syndrome | <syndrome> Congenital absence (partial or complete) of abdominal muscles, in which the outline of the intestines is visible through the protruding abdominal wall; in males, genitourinary anomalies (urinary tract dilation and cryptorchidism) are also found; genetics unclear. (05 Mar 2000) |
| adult lactase deficiency | Onset of lactase deficiency, with resulting milk intolerance and malabsorption, in adulthood. Inherited forms may not be manifested until adulthood; any process that damages the intestinal lining cells can cause lactase deficiency in adults. (05 Mar 2000) |
| alpha-1 antitrypsin deficiency | <chest medicine> Deficiency of the protease inhibitor alpha-1 antitrypsin, leads primarily to degradation of elastin of the alveolar walls, as well as other structural proteins of a variety of tissues. The lack of this protein leads to damage of various organs, but mainly to the lung and liver. symptoms may become apparent at a very early age or in adulthood, manifesting either as shortness of breath or liver related symptoms (jaundice, fatigue, fluid in the abdomen, mental changes, or gastrointestinal bleeding). There are several options for treatment of the lung disease, including replacement of the missing protein. Treatment of the liver disease is a well-timed liver transplant (12 Dec 1998) |